Dr Ashleys Limited

Dr Ashleys Limited is a Cayman Island registered pharmaceutical company with Registered office in Hong Kong corporate Center Latvija and USA. pharmaceutical trailblazer & a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for pharma and biotech companies. Dr Ashleys Limited’s capabilities span a wide range of development technologies and specialties—all backed by comprehensive industry knowledge and experience. Whether you need a partner in development or an experienced leader to navigate complex scale-up, Dr Ashleys is the final destination. Our deep knowledge of APIs manufacturing and processes is supported by a collaborative, consultative approach to ensure your expectations and milestones are met. Extensive portfolio of generic APIs. Our products cover a wide range of therapeutic classes, such as anti-cancer, anti-malarial, and pain management. Our APIs offering is supported by our network of GMP-compliant commercial manufacturing facilities in Europe and North America, to meet your global product requirements. Dr Ashleys Limited has made strategic partnership with leading manufacturing units worldwide to cater to the growing demands of the companies. We have a presence of more than 60 countries with a dedicated R&D facility at Riga in Latvia. Dr Ashleys Limited was born in the year 2012 as a pharmaceutical company to deliver world-class products. Over the years, Dr Ashleys has witnessed Exponential growth in meeting with clients complex demands of delivering world-class products as a reliable & trusted partner. Our vision is to be the world’s most trusted, reliable and innovative drug development and delivery partner by upholding the highest industry standards and exceeding customer expectations, while driving strong, sustained growth for the company. Our corporate responsibility (CR) strategy and commitments represent how we put our values into action to run our business and achieve